Trimethoprim sulphamethoxazole in neonatal Flavobacterium meningosepticum infection

Insights

Trimethoprim-sulfamethoxazole effectively treated Flavobacterium meningosepticum sepsis in neonates, achieving an 89% cure rate with minimal side effects. This antibiotic is a viable option for neonatal intensive care units facing F. meningosepticum outbreaks.

Area of Science:

  • Neonatal intensive care
  • Infectious diseases
  • Pharmacology

Background:

  • Neonatal intensive care units (NICUs) can experience outbreaks of serious bacterial infections.
  • Flavobacterium meningosepticum is a pathogen that can cause severe sepsis in neonates.
  • Effective antibiotic treatment options for neonatal sepsis are crucial.

Purpose of the Study:

  • To evaluate the efficacy and safety of intravenous trimethoprim-sulfamethoxazole for treating Flavobacterium meningosepticum sepsis in neonates.
  • To assess the clinical and bacteriological outcomes of this treatment regimen.

Main Methods:

  • A retrospective study of 9 infants treated with intravenous trimethoprim-sulfamethoxazole during an F. meningosepticum outbreak.
  • Monitoring of clinical response, bacteriological eradication, and adverse events.

Main Results:

  • Bacteriological cure was achieved in 8 out of 9 infants (89%).
  • One infant died due to massive intraventricular hemorrhage unrelated to the treatment.
  • No significant side effects were observed, apart from prolonged thrombocytopenia in one case.

Conclusions:

  • Intravenous trimethoprim-sulfamethoxazole demonstrates high efficacy in treating neonatal F. meningosepticum sepsis.
  • The drug is well-tolerated in neonates and possesses favorable pharmacokinetic properties, including blood-brain barrier penetration.
  • Trimethoprim-sulfamethoxazole should be considered a valuable therapeutic option for neonatal sepsis caused by F. meningosepticum.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...